window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : June 16, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Terumo BCT

  • Advanced Therapies,Drug Discovery & Development,Opinion & Events,Therapeutic Areas

    Terumo BCT and Santersus partner to advance therapeutic apheresis for sepsis treatment

    Terumo Blood and Cell Technologies (Terumo BCT) and Santersus AG [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Opinion & Events,Therapeutic Areas

    Terumo BCT and Hemex Health join forces to improve outcomes for sickle cell patients

    Terumo Blood and Cell Technologies (Terumo BCT), a global medical [...]

    May 5, 2026
  • Opinion & Events,Pharmaceuticals and therapeutics

    Kenya, Uganda and Côte d’Ivoire partner with Terumo Blood and Cell Technologies to build coordinated national care frameworks for sickle cell care

    Ministries of Health in Kenya and Côte d’Ivoire, together with [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Medical devices,Opinion & Events,Pharmaceuticals and therapeutics,Therapeutic Areas

    Terumo BCT expands access to rare disease therapies across Latin America

    Terumo Blood and Cell Technologies has announced regulatory approvals for [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Opinion & Events,Pharmaceuticals and therapeutics

    Terumo BCT and PwC Belgium join forces to break barriers in access to advanced cell and gene therapies

    Terumo Blood and Cell Technologies (Terumo BCT), a medical technology [...]

    May 5, 2026
  • Biotech & Pharma Business

    Terumo BCT appoints Patrick Daly as chief business officer to drive unified growth strategy

    May 5, 2026

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Scripps researchers develop stereoretentive radical chemistry for drug discovery
    Categories: Drug Discovery & Development, Pharmaceuticals and therapeutics
  • FDA grants orphan drug designation to Tris Pharma’s TRN-257 for idiopathic hypersomnia
    Categories: Clinical & Regulatory, Drug Delivery & Formulation, Pharmaceuticals and therapeutics, Therapeutic Areas
  • PhoreMost advances brain cancer candidate PMC-001 towards Phase 1
    Categories: Clinical & Regulatory, Drug Discovery & Development, Pharmaceuticals and therapeutics, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top